High-fat, low-carb ketogenic diet has been shown to have an inhibitory effect on cancer Drug review dynamics: Several new Class 1 drugs are expected to be approved, and the first blockbuster generic c ...
Shares of Checkpoint Therapeutics rose 4.6% to $3.84 in post-market trading after the Food and Drug Administration approved Unloxcyt (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma, ...